MICHELLE GALPERIN: Open Payments
NPI 1184269904 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,626 in 67 payments from 7 companies in 2025. Trend: 2023 $914 · 2024 $822 · 2025 $1,626
Food & beverage: $1,626
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $835 |
| ABBVIE INC. | 30 | $507 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $204 |
| Aimmune Therapeutics, Inc. | 1 | $26 |
| Sandoz Inc. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Lilly USA, LLC | 1 | $14 |
Products named: TREMFYA, RINVOQ, ENTYVIO, SKYRIZI, VOWST, HYRIMOZ, XIFAXAN, OMVOH.
Industry payments across NY — which companies pay providers there.
